Alkem Laboratories Ltd. (ALKEM): Alkem Laboratories Share Price rises 3.03% as stock gains today
- September 18, 2026
- Posted by: Harsh Piplani
- Category: News
Alkem Laboratories Share Price moved higher today, with the stock at Rs 5,501.60, up 3.03% from the previous close of Rs 5,340. The company’s market capitalisation stands at Rs 62,041.68 crore, placing the move in a large-cap pricing context by value, not by quality. The day’s gain of Rs 161.60 came after an open at Rs 5,340.90, and the share price touched an intraday high of Rs 5,501.60 and a low of Rs 5,310.35. The verified data confirms the price event, but it does not establish a company-specific catalyst. For readers tracking Alkem Laboratories Share Price Today, this Alkem Laboratories Stock News update focuses on what the numbers show and what investors can monitor next.
In the broader market conversation around Stock Market Today and Share Market Today, Alkem Laboratories is among the Stocks in News because of the day’s share price gain. Univest is using only the supplied data here, so the note stays factual: price, turnover, market cap and valuation context are all visible, while the cause of the move remains unconfirmed.
Alkem Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 5,501.6 |
| Previous Close | Rs 5,340 |
| Today's Move | Rs 161.6 (+3.03%) |
| Open | Rs 5,340.9 |
| High | Rs 5,501.6 |
| Low | Rs 5,310.35 |
| Turnover | Rs 13.81 crore |
| Market Capitalisation | Rs 62,041.68 crore |
| Market Cap Category | Large Cap |
Alkem Laboratories Ltd. (ALKEM) rose to Rs 5,501.6 from the previous close of Rs 5,340, a move of Rs 161.6 or 3.03%. The stock opened at Rs 5,340.9, reached a high of Rs 5,501.6, recorded a low of Rs 5,310.35.
Alkem Laboratories Share Price rose 3.03% today from Rs 5,340 to Rs 5,501.60. The move added Rs 161.60 to the prior close, and the stock finished at the day’s high of Rs 5,501.60 after opening at Rs 5,340.90. The low for the session was Rs 5,310.35, which shows that the price held above the day’s opening level for the rest of the move. Turnover for the session stood at Rs 13.81 crore. This is the factual picture for Alkem Laboratories Share Price Today: a clear same-day price rise, a positive close relative to the previous close, and a trading range that stayed within the day’s listed band.
For Alkem Laboratories Share Price Live readers, the move is relevant because it is measurable, recent and confirmed by the day’s price range. The data supports a share price rise narrative, but not a catalyst narrative. Univest is therefore treating the event as a verified market update rather than a reason-led announcement.
Alkem Laboratories Ltd. (ALKEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 62,041.68 crore |
| P/E Ratio | 29.59x |
| P/B Ratio | 4.46x |
| ROE | 18.29% |
| ROCE | 21.28% |
| EPS | Rs 180.45 |
| Book Value Per Share | Rs 1,196.51 |
| Dividend Yield | 0.99% |
Alkem Laboratories Ltd. (ALKEM) fundamental metrics show P/E 29.59x, P/B 4.46x, ROE 18.29%, ROCE 21.28%. These figures provide context only and are not a buy or sell signal.
Alkem Laboratories Ltd. has a market capitalisation of Rs 62041.68 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 29.59x, P/B at 4.46x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.29% and ROCE of 21.28%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 180.45, book value per share of Rs 1196.51, dividend yield of 0.99%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.69x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 29.59x |
| Benchmark Median P/E | 32.69x |
| Benchmark Average P/E | 44.72x |
| Benchmark P/E Range | 3.44x to 417.17x |
| Company P/B Ratio | 4.46x |
| Benchmark Median P/B | 3.1x |
| Company ROE | 18.29% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 21.28% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 62,041.68 crore |
| Benchmark Median Market Cap | Rs 741.38 crore |
Alkem Laboratories Ltd. (ALKEM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Alkem Laboratories Ltd. (ALKEM) has a P/E ratio of 29.59x, which is below the benchmark median of 32.69x, a difference of -9.48%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Alkem Laboratories Ltd. (ALKEM) has a ROE of 18.29%, which is above the benchmark median of 11.78%, a difference of +55.26%. Alkem Laboratories Ltd. (ALKEM) has a ROCE of 21.28%, which is above the benchmark median of 13.65%, a difference of +55.9%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,44,716.74 | 37.01 | 5.18 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,44,223.13 | 84.83 | 14.05 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,83,453.32 | 85.3 | 20.73 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,10,224.17 | 25.14 | 4.21 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,09,848.55 | 32.89 | 3.15 | 11.83 | 16 |
Alkem Laboratories Ltd. (ALKEM) has a P/E ratio of 29.59x compared with the displayed peer median of 37.01x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.29% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 21.28% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Alkem Laboratories Ltd. (ALKEM) has a market capitalisation of Rs 62,041.68 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Alkem Laboratories
- Alkem Laboratories Share Price rose 3.03% today to Rs 5,501.60, with a gain of Rs 161.60 from the previous close.
- The day’s range was Rs 5,310.35 to Rs 5,501.60, and the stock finished at the session high.
- Turnover for the session stood at Rs 13.81 crore, which is a factual traded-value measure.
- P/E is 29.59, P/B is 4.46, ROE is 18.29% and ROCE is 21.28%.
- Within the same industry benchmark, ROE and ROCE are above the median and average levels.
About Alkem Laboratories
Alkem Laboratories Ltd. is part of the Healthcare sector and operates in Pharmaceuticals & Drugs. The company’s business is reflected in its listed market profile rather than in detailed segment disclosure here, so this note stays focused on the supplied company facts. For readers following Alkem Laboratories Share Price and Alkem Laboratories Share Price Today, the main point is that the business sits within a large and active Indian pharmaceuticals universe.
The company’s market capitalisation is Rs 62,041.68 crore, with valuation and return ratios that can be compared against its listed peers and industry benchmark. Alkem Laboratories Stock News searches often focus on price movement, company financials and peer positioning, and those are the same elements covered in this Univest update. The article keeps the company overview factual and free of unsupported corporate claims.
Track Alkem Laboratories Share Price on Univest
Use Alkem Laboratories Ltd. (ALKEM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Alkem Laboratories Share Price rising today?
Ans. The verified data confirms that Alkem Laboratories Share Price rose 3.03% today, but it does not establish a company-specific catalyst. The move is measurable through the day’s price range, close and turnover.
What is Alkem Laboratories Share Price today?
Ans. Alkem Laboratories Share Price today is Rs 5,501.60, up Rs 161.60 from the previous close of Rs 5,340. The stock also recorded a day high of Rs 5,501.60 and a low of Rs 5,310.35.
What is the market capitalisation of Alkem Laboratories?
Ans. Alkem Laboratories has a market capitalisation of Rs 62,041.68 crore. That places it well above the industry benchmark median in the supplied healthcare peer universe, while still below the benchmark average.
How does Alkem Laboratories look on valuation?
Ans. Alkem Laboratories trades at a P/E of 29.59 and a P/B of 4.46. In the same industry benchmark, its P/E sits below the median, while its P/B is slightly above the average.
What do Alkem Laboratories profitability ratios show?
Ans. Alkem Laboratories reports ROE of 18.29% and ROCE of 21.28%. Both are above the supplied industry benchmark median and average, which provides useful context for Alkem Laboratories Share Price analysis.
How do EPS, book value and dividend yield read for Alkem Laboratories?
Ans. EPS is Rs 180.45, book value per share is Rs 1,196.51 and dividend yield is 0.99%. These figures add context to Alkem Laboratories Share Price by showing earnings, accounting value and payout information.
